Saito Masahide, Kadoya Noriyuki, Kimura Yuto, Nemoto Hikaru, Tozuka Ryota, Jingu Keiichi, Onishi Hiroshi
Department of Radiology, University of Yamanashi, Yamanashi, Japan.
Department of Radiation Oncology, Tohoku Univ. Graduate School of Medicine, Sendai, Japan.
J Appl Clin Med Phys. 2024 Dec;25(12):e14519. doi: 10.1002/acm2.14519. Epub 2024 Sep 16.
This study evaluates deep learning (DL) based dose prediction methods in head and neck cancer (HNC) patients using two types of input contours.
Seventy-five HNC patients undergoing two-step volumetric-modulated arc therapy were included. Dose prediction was performed using the AIVOT prototype (AiRato.Inc, Sendai, Japan), a commercial software with an HD U-net-based dose distribution prediction system. Models were developed for the initial plan (46 Gy/23Fr) and boost plan (24 Gy/12Fr), trained with 65 cases and tested with 10 cases. The 8-channel model used one target (PTV) and seven organs at risk (OARs), while the 10-channel model added two dummy contours (PTV ring and spinal cord PRV). Predicted and deliverable doses, obtained through dose mimicking on another radiation treatment planning system, were evaluated using dose-volume indices for PTV and OARs.
For the initial plan, both models achieved approximately 2% prediction accuracy for the target dose and maintained accuracy within 3.2 Gy for OARs. The 10-channel model outperformed the 8-channel model for certain dose indices. For the boost plan, both models exhibited prediction accuracies of approximately 2% for the target dose and 1 Gy for OARs. The 10-channel model showed significantly closer predictions to the ground truth for D50% and Dmean. Deliverable plans based on prediction doses showed little significant difference compared to the ground truth, especially for the boost plan.
DL-based dose prediction using the AIVOT prototype software in HNC patients yielded promising results. While additional contours may enhance prediction accuracy, their impact on dose mimicking is relatively small.
本研究使用两种类型的输入轮廓评估基于深度学习(DL)的头颈部癌(HNC)患者剂量预测方法。
纳入75例接受两步容积调强弧形放疗的HNC患者。使用AIVOT原型(日本仙台市的AiRato.Inc)进行剂量预测,这是一款具有基于高清U-Net的剂量分布预测系统的商业软件。针对初始计划(46 Gy/23次分割)和推量计划(24 Gy/12次分割)开发模型,用65例病例进行训练,10例病例进行测试。8通道模型使用一个靶区(PTV)和七个危及器官(OARs),而10通道模型增加了两个虚拟轮廓(PTV环和脊髓PRV)。通过在另一个放射治疗计划系统上进行剂量模拟获得的预测剂量和可交付剂量,使用PTV和OARs的剂量体积指数进行评估。
对于初始计划,两个模型的靶区剂量预测准确率均达到约2%,OARs的准确率保持在3.2 Gy以内。对于某些剂量指数,10通道模型优于8通道模型。对于推量计划,两个模型的靶区剂量预测准确率约为2%,OARs为1 Gy。10通道模型在D50%和Dmean方面的预测与真实值显著更接近。基于预测剂量的可交付计划与真实值相比差异不大,尤其是推量计划。
在HNC患者中使用AIVOT原型软件进行基于DL的剂量预测取得了有前景的结果。虽然额外的轮廓可能会提高预测准确率,但它们对剂量模拟的影响相对较小。